🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Singapore / NCT03813290
Recruiting Not applicable

A Neuro-Technological Intervention for Adolescents With GAD

NCT03813290 · tracked via the Priya Life Science Singapore tracker
Sponsor
National Healthcare Group, Singapore
Phase
Not applicable
Started
2020-12-08
Last updated
2025-05-22

Condition(s) studied

Generalised Anxiety Disorder

Investigational drug(s) / intervention(s)

Neuro-technological Intervention

Neuro-technological Intervention: During the intervention sessions, participants will don a head-mounted VR display set and a mobile EEG-biosensor. Each session will begin with a brief audio-guided mindfulness practice, follow by a 15 minutes VR game. Game performances will be influenced by individual's level of anxiety arousal and ability to regulate it.

Study summary

This study aims to evaluate the safety and acceptability of a basic neuro-technological intervention in the treatment of adolescents with Generalised Anxiety Disorder (GAD). Our technology will deliver a mindfulness-based anxiety regulation intervention through a neuro- / bio-feedback-based virtual reality (VR) game interface that is driven by a novel algorithm.

Eligibility

Sex
ALL
Min age
13 Years
Max age
18 Years
Healthy volunteers
No
Inclusion Criteria: * Between 13 to 18 years of age inclusive * Literate in English Language * Newly diagnosed with Generalised Anxiety Disorder: current episode, based on Computerised Diagnostic Interview Schedule for Children (C-DISC) * If on medication, dosage stable or unchanged for at least preceding 8 weeks * Has parental consent Exclusion Criteria: * Diagnosis (as defined by DSM-5) of: anxiety disorder induced by medication, substance, or another medical condition; obsessive compulsive disorder; bipolar disorder; any psychotic disorder (lifetime); intellectual disability (i.e. IQ\<70); autism spectrum disorder; attention-deficit/hyperactivity disorder * History of substance or drug use disorder (as per DSM-5 criteria) within the last 3 months * Neurological disorders or insults (e.g. epilepsy, cerebrovascular accidents) * Metal in the cranium, skull defects, or skin lesions on scalp (e.g. cuts, abrasion, rash) at proposed electrode sites * Irregular heart rhythms or heart problems * Severe visual or hearing impairment * Prior experience with mindfulness-based therapy (e.g. mindfulness-based stress reduction \[MBSR\], mindfulness-based cognitive therapy \[MBCT\])

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Child Guidance Clinic Singapore Singapore Recruiting

More National Healthcare Group, Singapore trials in Singapore

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03813290 on ClinicalTrials.gov ↗ ← All trials in Singapore